We undertake interdisciplinary research and associate with various scientific and academic institution of repute towards developing novel healthcare products.
The core function of the Medical device division is to accelerate interdisciplinary medical device research and development. This division focuses on the development of products like implants, drug delivery systems, nanomaterials, prophylactics etc.
The Pharma Division focuses on development of NCE formulations, Generic formulations, novel products with an objective to introduce better patient compliance. Pharma Division has the state of the art infrastructure to develop various dosage forms.
The Diagnostic division offers a comprehensive menu covering application in Molecular biology, Microbiology, Immunology and Molecular Genetics. This division is engaged with the development of early & accurate detection device and assays.
Emily is an affordable alternative for the Levonorgestrel releasing IUS meant for contraception and having a noteworthy effect on addressing abnormal uterine bleeding too.
The developed Natural latex female condom is a cost effective, non-inferior, alternative female condom compared to the existing female condoms in the market.
Happy Days Silver is an improved value-added version of the existing sanitary napkin “Happy Days” with added features like anti-bacterial and anti-odour properties.
Candidates who wish to do registration for Ph.D under Faculty of Science with Cochin University are welcome to register at our centre. The details of PhD registration can be viewed at www.cusat.ac.in
HLL CRDC offers finishing courses in a) Diagnostics, b) Implant & Devices and c) Pharma. The duration of the programme is one month each in different verticals. The finishing course is aimed to equip a fresh graduate /post graduate with the right kind of skills required for industry/academia.
HLL CRDC is a recognized research center with Cochin University of Science & Technology (CUSAT) No Ac/B1/015270/HLL/2011 dated 5-04-2018
Joint winner of 7th National award for the technology innovation in polymers in public healthcare with Regional Cancer Centre for “Cervical Spacer for Reducing Radiation Dosage on Critical Organs during Branchytherapy Treatment” From Government of India.
Three of the innovative ideas from CRDC won the prestigious grand challenge exploration worth USD 2.2 million.
HLL CRDC is registered with the Department of Science & Industrial Research(DSIR) and this registration is valid upto 31.03.2021[Reg No : - F.No.TU/IV-RD/1179/2017]